Relationship between human platelet antigen-1 gene polymorphism and clopidogrel resistance in patients with coronary artery disease

1998 ◽  
Vol 79 (04) ◽  
pp. 731-735 ◽  
Author(s):  
Rainer Zotz ◽  
Bernhard Winkelmann ◽  
Markus Nauck ◽  
Günther Giers ◽  
Beate Maruhn-Debowski ◽  
...  

SummaryConflicting results of an association between the human platelet antigen 1b (HPA-1b or PlA2) allele and the risk of myocardial infarction and coronary artery disease have been reported. To assess the reason for this discrepancy, we determined the HPA-1 genotype in 298 men who had undergone coronary angiography, including 124 individuals with myocardial infarction, 83 individuals with coronary artery disease but no history of myocardial infarction, and 91 control patients. Among patients with acute or recent onset myocardial infarction (<1 year), the prevalence of HPA-1b was higher than among patients with coronary artery disease but without myocardial infarction (33 percent vs. 14 percent, p = 0.016). In patients under 60 years of age this difference was even more pronounced (45 percent vs. 15 percent, p = 0.003). Unlike conventional risk factors HPA-1b does not represent a risk factor for coronary artery disease itself but appears to be associated with increased platelet thrombogenicity.


2016 ◽  
Vol 72 (3) ◽  
Author(s):  
Akbar Hedayatizadeh-omran ◽  
Alireza Rafiei ◽  
Reza Alizadeh-Navaei ◽  
Rezvan Khajavi ◽  
Abulghasem Ajami ◽  
...  

2021 ◽  
Vol 10 (15) ◽  
pp. 3413
Author(s):  
Afrouz Behboudi ◽  
Tilia Thelander ◽  
Duygu Yazici ◽  
Yeliz Celik ◽  
Tülay Yucel-Lindberg ◽  
...  

Obstructive sleep apnea (OSA) is common in patients with coronary artery disease (CAD), in which inflammatory activity has a crucial role. The manifestation of OSA varies significantly between individuals in clinical cohorts; not all adults with OSA demonstrate the same set of symptoms; i.e., excessive daytime sleepiness (EDS) and/or increased levels of inflammatory biomarkers. The further exploration of the molecular basis of these differences is therefore essential for a better understanding of the OSA phenotypes in cardiac patients. In this current secondary analysis of the Randomized Intervention with Continuous Positive Airway Pressure in CAD and OSA (RICCADSA) trial (Trial Registry: ClinicalTrials.gov; No: NCT 00519597), we aimed to address the association of tumor necrosis factor alpha (TNF-α)-308G/A gene polymorphism with circulating TNF-α levels and EDS among 326 participants. CAD patients with OSA (apnea–hypopnea-index (AHI) ≥ 15 events/h; n = 256) were categorized as having EDS (n = 100) or no-EDS (n = 156) based on the Epworth Sleepiness Scale score with a cut-off of 10. CAD patients with no-OSA (AHI < 5 events/h; n = 70) were included as a control group. The results demonstrated no significant differences regarding the distribution of the TNF-α alleles and genotypes between CAD patients with vs. without OSA. In a multivariate analysis, the oxygen desaturation index and TNF-α genotypes from GG to GA and GA to AA as well as the TNF-α-308A allele carriage were significantly associated with the circulating TNF-α levels. Moreover, the TNF-α-308A allele was associated with a decreased risk for EDS (odds ratio 0.64, 95% confidence interval 0.41–0.99; p = 0.043) independent of age, sex, obesity, OSA severity and the circulating TNF-α levels. We conclude that the TNF-α-308A allele appears to modulate circulatory TNF-α levels and mitigate EDS in adults with CAD and concomitant OSA.


2017 ◽  
Vol Volume 8 ◽  
pp. 13-18
Author(s):  
Waleed Abdou Hamed ◽  
Ghada E Hammouda ◽  
Sally M El-Hefnawy ◽  
Eman M Abd El-Gayed

2013 ◽  
Vol 20 (7) ◽  
pp. 749-754 ◽  
Author(s):  
Ibrahim Faruk Akturk ◽  
Fatma Nihan Caglar ◽  
Mehmet Erturk ◽  
Nilgun Tuncer ◽  
Ahmet Arif Yalcın ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document